Release date: 2016-01-04
Recently, AWSensors has teamed up with the European project LIQBIOPSENS team to develop a new liquid biopsy technology for early diagnosis of colorectal cancer, which can help cancer diagnosis quickly and easily, while monitoring cancer, compared to current Diagnostic technology saves two-thirds of the cost.
Developed by Spain's AWSensors, this highly sensitive molecular diagnostic system can be used for cancer screening, a liquid biopsy-based technique that analyzes small liquid samples similar to blood or saliva. The diagnosis of cancer is completely non-invasive, and the technique can give test results within an hour. When combined with genome analysis, it is possible to obtain reliable diagnostic results and help with the development of advanced cancer treatments. .
This new diagnostic system will be combined with the quartz microsensor technology developed by the Valencia Polytechnic University. Quartz microsensor technology can provide real-time analysis, and the combination of the two can reliably detect DNA mutations. The new detection system will be used to test blood samples from patients with colorectal cancer over the next three years, and colorectal cancer is currently the second leading cause of cancer death in Europe and is common in breast, lung and prostate cancers. cancer.
The current preferred method for reliable cancer diagnosis is tumor biopsy, but the method is invasive and painful and expensive for the patient, and the technique can only provide patients with a single aspect of disease progression; The development of this new system is at least three times less expensive than current real-time monitoring methods, such as real-time quantitative PCR. Researchers have developed the LiqBiopSens program to develop simple, inexpensive, and non-invasive methods for early diagnosis and monitoring of cancer.
By detecting DNA released from body tumor tissue and cancer-associated mutations, the new technology reliably diagnoses the presence and evolution of cancer and avoids false positive results. At present, AWSensors has begun to use crystals to make sensors so that it can work efficiently and better detect the molecular differences between different liquid biopsy tissues and materials.
Source: Bio Valley
Zhuhai Mingke Electronics Technology Co., Ltd , https://www.zhmkdz-electronics.com